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Alzheimer’s disease (AD) is an age-related irreversible neurodegenerative disorder
characterized by extracellular β Amyloid(Aβ) deposition, intracellular neurofibrillary
tangles and neuronal loss. The dysfunction of neurogenesis and increased degeneration
of neurons contribute to the pathogenesis of AD. We now report that miR-211-5p, a
small non-coding RNA, can impair neurite differentiation by directly targeting NUAK1,
decrease neuronal viability and accelerate the progression of Aβ-induced pathologies.
In this study, we observed that during embryonic development, the expression levels
of miR-211-5p were down-regulated in the normal cerebral cortexes of mice. However,
in APPswe/PS11E9 double transgenic adult mice, it was up-regulated from 9 months
of age compared to that of the age-matched wild type mice. Studies in primary cortical
neuron cultures demonstrated that miR-211-5p can inhibit neurite growth and branching
via NUAK1 repression and decrease mature neuron viability. The impairments were more
obvious under the action of Aβ. Our data showed that miR-211-5p could inhibit cortical
neuron differentiation and survival, which may contribute to the synaptic failure, neuronal
loss and cognitive dysfunction in AD.
Keywords: microRNA-211-5p, NUAK1, neurite branching, neuronal viability, amyloid β (Aβ), Alzheimer’s disease
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INTRODUCTION
Neurogenesis, or the ability of the brain to generate new neurons, was thought originally to occur
only during brain development in the fetus and young child (Nixon et al., 2010). Recently, the
presence of postnatal neurogenesis events referred to as adult neurogenesis has been demonstrated.
Few but critical differences have been reported between embryonic and adult forms of neurogenesis
(Temple, 2001). In mammalian brains, adult neurogenesis is limited to specific brain regions, such
as the hippocampal dentate gyrus and the subventricular zone/olfactory bulb system (Winner and
Winkler, 2015). The rate of adult neurogenesis declines with age (Altman and Das, 1965; Altman
and Das, 1966; He and Crews, 2007; Manganas et al., 2007). An important aspect regarding adult
Abbreviations: AD, Alzheimer’s disease; Aβ, β amyloid peptide; miRNA, microRNA; APP, amyloid precursor protein; DIV,
days in vitro; NPC, neural progenitor cells; PS1, presenilin 1; WT, wild type.
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neurogenesis is its modulation resulting from a variety of genetic,
epigenetic, and transcriptional factors as well as environmental
factors, age, and acute and chronic diseases (Ma et al., 2010;
Mu et al., 2010; Winner and Winkler, 2015). Impaired adult
neurogenesis has been shown in numerous animal models of
neurodegenerative diseases (Winner et al., 2011). Alterations in
adult neurogenesis appear to be a common hallmark of different
neurodegenerative diseases, indicating that in addition to the
loss of mature neurons, the endogenous ability of the adult
brain to renew neurons and the putative functions of these new
neurons are also damaged or even lost (Winner and Winkler,
2015).
Alzheimer’s disease is the most common human
neurodegenerative disease, with more than 30 million sufferers
worldwide and is characterized by gradual memory loss,
cognitive impairments, and deterioration of language skills
(Zhou et al., 2011). The neurite atrophy and synaptic loss
induced by β Amyloid (Aβ) are considered to be the major causes
of gradual cognitive deterioration in AD (Masliah et al., 2001;
Selkoe, 2002). Recently, more studies showed that impairment
of adult neurogenesis occurred in AD brains much earlier than
neuronal loss. Understanding the mechanisms of changes in
neurogenesis due to AD might give some clues for AD diagnosis
and treatment.
NUAK1 is a member of the novel (Nua) kinases family
with the alternative names ARK5 or OMPHK1 (Bekri et al.,
2014). A number of previous studies indicated that NUAK1
was involved in regulation of proliferation, promotion of cell
survival, invasion, and metastasis, induction of senescence and
loss of cellular adhesion (Suzuki et al., 2003; Hou et al.,
2011; Lu et al., 2013; Sun et al., 2013; Bell et al., 2014;
Shi et al., 2014). It has been reported that NUAK1 regulates
both axon growth and branching involved in neurogenesis
(Courchet et al., 2013), but little is known about its role in AD
pathologies.
MiRNAs are small non-coding RNAs which mainly bind
to the 3′ untranslated region (3′-UTR) of target mRNAs and
induce mRNA degradation or the inhibition of translation
(Lagos-Quintana et al., 2001). An individual miRNA can down-
regulate hundreds of mRNA targets by interacting with partially
complementary sequences within their 3′UTRs. Our previous
study found that miR-211-5p was up-regulated in the cortexes of
APPswe/PS11E9 double transgenic mice, which are commonly
used as an AD mouse model, suggesting the pivotal role of
miR-211-5p in AD pathology (Luo et al., 2014). NUAK1 has
been demonstrated to be one of the targets of miR-211-5p with
three miR-211-5p binding sites in its 3′UTR (Bell et al., 2014).
Studies have shown that miR-211-5p regulates cell proliferation,
differentiation, survival, invasion, and metastasis (Asuthkar et al.,
2012; Cai et al., 2012; Bell et al., 2014; Xia et al., 2015).
However, there are no relative reports about the role of miR-
211 in neuronal differentiation and neurodegenerative diseases
at present.
In this study, we found that miR-211-5p regulated neurite
outgrowth by targeting NUAK1. This pathway also plays
an important role in aggravating Aβ-triggered neuronal cell
impairment.
MATERIALS AND METHODS
Animals
All procedures involving animal experiments were in accordance
with animal use protocols approved by the Committee for the
Ethics of Animal Experiments, Shenzhen-Peking University-
The Hong Kong University of Science and Technology Medical
Center (SPHMC; protocol number 2011-004). Double-transgenic
mice (APPswe/PS1E9) (held by The Jackson Laboratory, strain
name: 117 “B6.Cg-Tg (APPswe, PSEN11E9)85Dbo/Mmjax)”
(Borchelt et al., 1996) and their corresponding WT controls
(C57BL/6J mice) were purchased from the Model Animal
Research Center of Nanjing University. ICR mice were purchased
from Guangdong Medical Lab Animal Center. All the mice were
raised in a temperature-controlled room with free access to food
and water, and 12 h light–dark cycle. APPswe/PS1E9 mice and
their non-transgenic littermates, as well as ICR mice at different
age stages were used in this study. The mice were anesthetized
with pentobarbital (50 mg/kg). Once removed and dissected, the
cortexes of the brains were frozen in TRIzol Reagent (Invitrogen)
for RNA extraction or in liquid nitrogen for protein extraction.
DNA Constructs and miRs
Mouse NUAK1 cDNA was amplified by PCR from image
clone 30355405 (accession number BC082328; Open Biosystems)
followed by insertion into PT-GFP vector (a modified vector from
pEGFP-C1) by XhoI and EcoRI enzyme sites (Courchet et al.,
2013). The mimic and inhibitor of miR-211-5p and controls were
purchased from Ribo Bio Company.
Cell Culture and Transfection
Neuro2A cells, a mouse neuroblastoma cell line, were cultured
in DMEM (GIBCO) containing 10% fetal bovine serum
(Hyclone), 50 U/ml penicillin and 50µg/ml streptomycin
(GIBCO). Mouse primary cortical neurons from E18.5 mouse
embryos were cultured on Poly-L-Lysine (PLL)-coated culture
plates in Neurobasal medium containing B27 supplement,
0.05 mM glucose, and 0.5 mM L-glutamine. Cells were
grown in a humidified incubator at 37◦C with 5% CO2. For
immunofluorescence, neurons were maintained on coverslips.
TABLE 1 | Sequence of primers and probes.
Primer/probe name Sequence
U6-F 5′-GCTTCGGCAGCACATATACTAAAAT-3′
U6-R 5′-CGCTTCACGAATTTGCGTGTCAT-3′
MiR-211-5p-F 5′-GATCTTCCCTTTGTCATCC-3′
Has miR-R 5′-GTGTCGTGGAGTCGGCAA-3′
MiR-211-5p-RT 5′-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATT
GCACTGGATACGACAGGCAA-3′
MsGAPDH-F 5′-AACTTTGGCATTGTGGAAGG-3′
MsGAPDH-R 5′-GGATGCAGGGATGATGTTCT-3′
MsNUAK1-F 5′-GAGCCCACTCTATGCGTC-3′
MsNUAK1-R 5′-ATGTCCTCGATGGTGGCT-3′
MiR-211-5p probe 5′-FAM-CACTGGATACGACAGGCAAAGGAT-TAMRA-3′
U6 probe 5′-FAM-CCTTGCGCAGGGGCCATGCTAATC-TAMRA-3′
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FIGURE 1 | MiR-211-5p regulates NUAK1 expression in Neuro-2a cells and primary mouse cortical neurons. (A) and (B) miR-211-5p mimic (100 nM) or
inhibitor (100 nM) was transfected into Neuro2A cells. After 24 h (RNA) to 48 h (protein), NUAK1 mRNA (A) or protein (B) levels were assessed by qRT-PCR or
western blotting, respectively. The results were shown as the mean ± SD (∗∗p < 0.01). Three independent experiments were performed. (C) Western blot analysis of
NUAK1 protein level in primary cortical neurons transfected with miR-211-5p mimic (1 µM) or inhibitor (1 µM) for 48 h. Image J software was used to quantify the
gray degree values. The results were shown as the mean ± SD (∗p < 0.05). Three independent experiments were performed.
Transfections were performed using Lipofectamine 2000 Reagent
(Invitrogen) according to the manufacturer’s instructions in
Neuro2A cells 12 h after plating. Primary cultured cortical
neurons were transfected immediately after culturing or at DIV7.
Preparation and Treatment of
Aggregated Aβ1-42
Aβ1-42 (Sigma) was initially dissolved in Hexafluoroisopropanol
(HFIP) to a final concentration of 1 mM. Next, HFIP was allowed
to evaporate in the fume hood. HFIP-treated samples were
completely re-suspended to 5 mM in dimethyl sulfoxide (DMSO)
(Sigma) by pipette mixing followed by diluting to 0.1 mM in
phosphate buffered saline (PBS). Next, the diluted Aβ1-42 was
incubated at 37◦C for overnight to induce aggregation.
RNA Extraction and qPCR
The RNA for qRT-PCR was extracted from mouse cortexes
through homogenate or cells using TRIzol reagent and then
was reverse transcripted as described in the previous study (Xia
et al., 2015). RNA expression levels were quantified either using
TaqMan probe (RiboBio) qPCR analysis or iQTM SYBRr Green
Supermix (Bio-Rad)-based qPCR assays. Standard curves and
normalization factors were used to calculate and normalize the
absolute copies of miR-211-5p as previously described (Wang Y.
et al., 2015). All qPCR reactions were carried out on a CFX96TM
Real-Time PCR detection system (Bio-Rad). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as the endogenous
control of mRNA while U6 snRNA was used as the housekeeping
gene of miRNA. Relative expression was calculated by using the
delta–deltaCt method. All the primer sequences are listed in
Table 1.
Western Blot Analysis
Mouse cortical tissues or cultured cells were lysed in RIPA buffer
[150 mM NaCl, 1% (v/v) Nonidet P-40, 0.5% deoxycholic acid,
0.1% (w/v) sodium dodecyl sulfate (SDS)] containing protease
inhibitors (cocktail, Sangon) and 1 mM phenylmethanesulfonyl
fluoride (Sigma) for 15 min. The lysates were centrifuged at
14000× g for 10 min at 4◦C. Protein samples (supernatants) were
immediately transferred into new tubes, and the concentration
was measured using Bradford Reagent (Sigma). After boiling
for 10 min at 98◦C, the samples were separated on SDS–poly-
acrylamide gel electrophoresis (PAGE) gels followed by
transferring onto nitrocellulose membranes (PALL). The
membranes were treated with the primary antibodies against
NUAK1 (Cell Signaling Technology, rabbit polyclonal antibody)
and GAPDH (Sangon, rabbit polyclonal antibody) overnight
at 4◦C following blocking with 5% (w/v) skim milk in TBS-T
(Tris-buffered saline containing 0.1% Tween-20) for 1 h. Next,
the membrane was washed with TBS-T buffer three times and
incubated with infrared-labeled secondary antibodies (Odyssey,
Goat anti-rabbit IR Dye @ 680 CW) at room temperature for
2 h. After washing, the membranes were finally scanned with
Odyssey v3.0. The intensity of each band was quantified using
Image J analysis.
Cell Viability Assays
Cell viability was assessed by measuring formazan produced
by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT). The amount of formazan is proportional
to the number of viable cells. MTT reagent was added to
primary cortical neurons with different treatments as indicated
at 1/10 volume of the medium. Cells were incubated for 4 h
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FIGURE 2 | Expression profile of miR-211-5p and NUAK1 in mice brains during development. (A) The absolute copies of miR-211-5p in the cortexes of ICR
mice during embryonic and postnatal development examined by TaqMan qRT-PCR were calculated and normalized using standard curves and normalization factors.
The result was shown as the mean ± SEM (n = 5 for E12.5 to P7; n = 3 for P14 to P60). (B) Relative expression of NUAK1 mRNA examined by qRT-PCR in the
cortexes during embryonic and postnatal development. The result was shown as the mean ± SEM (n = 2–5). (C) NUAK1 protein expression in the cortexes was
examined by Western blotting during embryonic and postnatal development. Gray degree values are quantified by Image J software. The result was shown as the
mean ± SEM.
at 37◦C. The medium with MTT was removed and formazan
crystals were dissolved in DMSO. The optical density was
determined at 490 nm using a microplate reader (Bio-Rad).
Cell viability was presented as percentage of the non-treated
control.
Immunofluorescence Imaging
Neurons were fixed for 30 min at room temperature in 4%
(w/v) paraformaldehyde. PBS containing 0.4% Triton X-100,
1% bovine serum albumin (BSA) (Sigma), 4% Goat Serum
was used for 30 min to permeabilize and block non-specific
staining. Neurons were incubated overnight at 4◦C with primary
antibody (anti-β-tubulin III, 1:800, Sigma, mouse monoclonal
antibody). After the incubation with the secondary antibody
(anti-mouse, CY3, 1:500, Jackson Immuno Research) for 2 h
at room temperature, the coverslips were mounted on slides
with anti-fade-mounting medium (Beyotime). The fluorescent
signals were observed using a fluorescence microscope. Length
and branch numbers of the longest neurites were quantified with
Image J analysis.
Statistical Analysis
Data are expressed as the mean± SEM for tissues or mean± SD
for cells. A Student’s t-test was utilized to perform the statistical
analysis using SPSS 19.0 software. A difference was considered
statistically significant if the p value was<0.05.
RESULTS
MiR-211-5p Modulates NUAK1 Levels in
Neuro2A Cells and Mouse Primary
Cultured Cortical Neurons
To determine whether NUAK1 is regulated by miR-211-5p
in Neuro2A cells and primary cultured cortical neurons, we
transfected cells with miR-211-5p mimic and inhibitor and
then examined the NUAK1 mRNA and protein levels. Over-
expression of miR-211-5p mimic resulted in a significant
decrease of NUAK1 mRNA and protein levels. However, miR-
211-5P inhibitor had no effect (Figure 1), indicating that
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FIGURE 3 | MiR-211-5p inhibits neurite growth and branching via its target NUAK1. (A) Mouse E18.5 primary cortical neurons were co-transfected with
PT-GFP and miR-211-5p mimic or inhibitor (concentration ratio 1:3) before culturing. After 5 days of culture, the cells were fixed and immunostained with anti-tubulin
III antibody. The longest neurite was observed and considered as the axon. (B–D) Quantitation of the longest neurite length or branches after overexpression or
inhibition of miR-211-5p by Image J software. The results were shown as the mean ± SD (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001). (E) Cortical neurons were
transfected with miR-211-5p with or without NUAK1 plasmid and similar experiments were performed as described in (A). (F–H) Quantitation of the longest neurite
length or branches by Image J software. The results were shown as the mean ± SD (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).
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FIGURE 4 | Expression profile of miR-211-5p and NUAK1 in APP/PS1 mice cortexes and Aβ-treated primary cortical neurons. (A) The absolute copies of
miR-211-5p in WT and APP/PS1 mice cortexes were examined by TaqMan qRT-PCR (five pairs of mice at each stage). The data were calculated and normalized
using standard curves and normalization factors. The result was shown as the mean ± SEM (∗p < 0.05, ∗∗p < 0.01, and n = 6). (B) Relative expression levels of
NUAK1 in the same mice cortexes as described in (A) by qRT-PCR analysis. The result was shown as the mean ± SEM (∗p < 0.05, ∗∗p < 0.01, and n = 5).
(C) NUAK1 protein levels in WT and APP/PS1 mice cortexes were examined by western blotting. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is used as
a reference gene. Gray degree values are quantified by Image J software. The result was shown as the mean ± SEM. (D,E) Mouse primary cortical neurons at DIV7
were treated with Aβ1-42 (1 µM) for different time intervals as indicated. MiR-211-5p expression was quantified by semi-quantitative RT-PCR with SYBR Green (D).
The result was shown as the mean ± SD (∗p < 0.05, ∗∗p < 0.01). NUAK1 protein expression was examined by Western blotting (E).
additional unknown mechanisms may also be involved in
NUAK1 regulation.
MiR-211-5p Inhibits Neurite Growth and
Branching via Targeting NUAK1
To gain insight into the role of miR-211-5p in neurogenesis,
qPCR, and Western blotting were performed to assess the
expression levels of miR-211-5p and NUAK1 during mouse
embryonic and postnatal cortex development. MiR-211-5p
expression is down-regulated during the embryonic development
after E12.5 followed by an increase after birth (Figure 2A).
NUAK1 mRNA and protein are highly expressed from E12.5 to
P0, which is in contrast to that of the miR-211-5p (Figures 2B,C).
During early neuronal differentiation cultured in vitro,
axons grow faster than dendrites and we focused our study
on the longest neurite and considered it as an axon. After
the transfection of miR-211-5p mimic or inhibitor, we found
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FIGURE 5 | miR-211-5p aggravates the insult of Aβ on neurite growth and branching. (A) Mouse primary cortical neurons were transfected with PT-GFP and
miR-211-5p mimic (500 nM) before culturing. Next, the cells were cultured for 3 days followed by Aβ1-42 treatment (7 µM) for 48 h. Neurites were immunostained
with anti-β-tubulin III antibody. (B–D) The longest neurite length and branch numbers were quantified of by Image J software. The results were shown as the
mean ± SD (∗p < 0.05, ∗∗p < 0.01). (E) Mouse primary cortical neurons were transfected with PT-GFP and miR-211-5p inhibitor (1 µM) and the same experiment
was performed as described in (A). (F–H) The longest neurite length and branch numbers were quantified by Image J software. The results were shown as the
mean ± SD (∗p < 0.05, ∗∗p < 0.01).
that neurons with the overexpression of miR-211-5p displayed
significantly decreased growth and branching of longest neurite,
whereas miR-211-5p inhibitor induced markedly increased
branching but without the length change (Figures 3A–C). In
order to examine whether the less-branched neurites could be
a secondary result of shorter neurites, the neurite number was
normalized for by neurite length. The result showed that the
longest neurite branching is still significantly reduced when
miR-211-5p was overexpressed (Figure 3D). As NUAK1 is one
of the targets of miR-211-5p, we further determined whether
NUAK1 could alleviate the insult of miR-211-5p on neurite
length and branching in cortical neurons. It was confirmed
that overexpression of NUAK1 could rescue miR-211-5p mimic-
induced neurite impairment (Figures 3E–H), indicating that
miR-211-5p inhibits both neurite growth and branching by
regulating NUAK1.
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FIGURE 6 | miR-211-5p increases Aβ cytotoxicity on neuron viability. (A) Mouse primary cultured cortical neurons were transfected with miR-211-5p mimic or
inhibitor at DIV7. Twenty-four hours later, the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was performed to evaluate the cell
viability. (B) Mouse primary cultured cortical neurons were transfected with miR-211-5p mimic or inhibitor at DIV7 for 24 h followed by Aβ1-42 treatment (10 µM) for
another 24 h. Next, the MTT assay was performed to evaluate the cell viability. The results were shown as the mean ± SD (∗p < 0.05, ∗∗p < 0.01).
MiR-211-5p-NUAK1 Pathway Is Involved
in Alzheimer’s Disease Pathologies
To explore the dynamic changes of miR-211-5p and NUAK1
expression during the development of AD pathology, we
examined their expression levels in the cortexes of APP/PS1
and WT mice with ages spanning from 2 to 18 months by
real-time quantitative PCR using TaqMan probe. MiR-211-
5p expression was significant higher in APP/PS1 mice than
that of WT mice beginning at 9 months of age (Figure 4A).
However, NUAK1 mRNA and protein levels have the opposite
expression patterns (Figures 4B,C). To further confirm their
results in a cell model, mouse cortical neurons were treated
with Aβ1-42 at DIV7 for different intervals. MiR-211-5p and
NUAK1 RNA levels were detected by semi-quantitative RT-
PCR using SYBR Green and the protein levels were examined
by Western blotting. The dynamic changes of miR-211-5p
and NUAK1 were consistent with that from mice tissues
(Figures 4D,E), indicating that miR211-5p-regulated NUAK1
pathway may have a relationship with the pathological process
of AD.
MiR-211-5p Aggravates the Insult of Aβ
on Neurite Growth and Branching
To determine whether the effect of miR-211-5p is involved in
Aβ1-42 impairment, we overexpressed miR-211-5p mimic or
inhibitor in cultured cortical neurons followed by Aβ treatment.
Overexpression of miR-211-5p mimic dramatically aggravated
the longest neurite length and branching damage induced by
Aβ (Figures 5A–D). However, miR-211-5p inhibitor protected
neurons from Aβ damage (Figures 5E–H).
MiR-211-5p Increases Aβ Cytotoxicity in
Neurons
In order to examine the role of miR-211-5p on neuron viability,
an MTT assay was performed after miR-211-5p mimic or
inhibitor transfection. The viability of primary cultured cortical
neurons was dramatically decreased with the overexpression
of miR-211-5p, whereas miR-211-5p inhibitor had no effect
(Figure 6A). When Aβ was treated together with miR-211-5p
overexpression, the cell death was further induced, but miR-211-
5p inhibitor showed no effect (Figure 6B).
DISCUSSION
Adult neurogenesis involves several crucial steps of neural
development and requires several processes to produce novel
neurons: neural stem cell proliferation, cell differentiation, cell
migration, and cell survival and/or integration, and each of these
processes is regulated independently (Nixon et al., 2010). NUAK1
is highly expressed in the cortex during embryonic development
and promotes axon extension and branching, affecting neuronal
differentiation (Courchet et al., 2013), which might be a potential
therapeutic approach for the repair of ischemic stroke (Wang Z.
et al., 2015). However, the role of NUAK1 mediated neuronal
differentiation in AD pathologies is unknown. Previous studies
have indicated that synaptic loss and neuronal death caused by
abnormal deposition of Aβ are the major cause of cognitive
deterioration in AD (Hardy and Selkoe, 2002; Kayed et al., 2003).
Neurogenesis plays a key role in the rescue of impaired neurons
and improvement of cognitive decline in AD mice (Bruel-
Jungerman et al., 2007; Deng et al., 2010). Our results showed that
miR-211-5p was up-regulated and NUAK1 was down-regulated
in both AD cell and mouse models. Although our data showed
NUAK1 protein levels go down at 15 months of age and come
back at 18 months old, we do not know the significance of this and
need more examination to avoid individual difference. MiR-211-
5p/NUAK1 was one of the pathways induced by Aβ to damage
neurogenesis, which was consistent with the previous studies
regarding impaired adult neurogenesis in AD transgenic models
(Winner et al., 2011; Winner and Winkler, 2015).
MiRNAs modulate cellular regulatory processes via their
ability to alter gene expression. Recent accumulating evidence has
implicated the dysregulation of miRNAs expression in AD (Luo
et al., 2014; Lei et al., 2015; Santa-Maria et al., 2015; Ye et al.,
2015; Zhu et al., 2015). Some studies have identified miRNAs
that are involved in AD by regulating neurogenesis. The amyloid
precursor protein intracellular domain (AICD) processed from
APP binds to regulatory regions of specific miRNAs in
the human genome and suppresses neuronal differentiation
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through transcriptional regulation of miRNAs, and thus results
in decreased neurogenesis (Shu et al., 2015). MiR-206 regulates
brain-derived neurotrophic factor which promotes neurogenesis
in an AD model (Lee et al., 2012). These findings demonstrate
the interesting link among miRNA, neurogenesis and AD. In
this study, we first combined the role of miRNA in embryonic
brain development and in AD pathologies. MiR-211-5p was not
only involved in neuronal differentiation at embryonic stage, but
also involved in Aβ-induced pathologies in an AD mouse model
by targeting NUAK1. The mechanism of miR-211-5p increase
induced by Aβ is still unknown, but our data shows that the
destructive role of miR-211-5p on neurogenesis participates in
the Aβ impairment of neurons. Although we found miR-211-
5p inhibitor could not affect NUAK1 expression, miR-211-5p
inhibitor alleviated the insult of Aβ on neurite growth and
branching in our study. However, there is no effect of miR-211-
5p inhibitor on neuron viability, indicating that there are more
factors involved in this complicated process, such as bcl-2 (An
et al., 2014).
Our work indicated that miR-211-5p may play a role in AD
development by affecting neurogenesis and neuronal viability. As
miRNAs play roles as a network during different processes, the
importance of miR-211-5p in Aβ-related pathologies still needs
detailed elucidation. We still need more animal experiments to
confirm the role of miR-211-5p further in AD. For example,
miR-211-5p knockout mice will be crossed with APP/PS1 mice
to further confirm the role of miR-211-5p in Aβ-induced
neurogenesis impairment. However, our study supports the
translational potential of miR-211-5p in AD diagnosis and
treatment in the future.
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